Flagship · Bulletin

Macro rationale

Signals genuinely cross and stay late-cycle NEUTRAL. Calm surface — VIX 18.77 flat, HY OAS 2.73 (18th pct, inside its 90d sma) — but forward ERP ~0.4%, forward P/E 20.3x and QQQ +8.54% >200d leave near-zero equity compensation. Extension + concentration escalators are ACTIVE (AI-load 36.5% NAV, over its 30% trigger), lifting the cash ceiling to 18% but not forcing a move within the base band. Labor decelerating (payrolls +57K, participation exodus), curve un-inverted (+37bp), Fed on a hawkish hold — against genuine June disinflation and an intact ~$725B hyperscaler capex cycle. Today's event (TSMC 2027 price hikes, memory price forecasts) validates the compute physical-bottleneck theses rather than shifting the regime. No escalator fired or cleared this week that would move cash within band; no regime change.

Thesis

Event-driven, scope-locked patch on an AI-memory/foundry rally (MU +12%, TSM +5.5%, TER +12%, SCCO +7.4%, FN +6.7%) driven by TSMC's 10% 2027 price hikes and Morgan Stanley's 25% memory-price forecast. Read: this is thesis CONFIRMATION for the compute physical-bottleneck leg (foundry/memory/optical) and the copper/uranium hedges, not a flow break or regime shift. stale_policy=YES blocks the only action I'd otherwise take — leaning into the rally with adds — so the disciplined output is a full re-affirmation at entry weights. The 44.73% AI-load is a LIVE (drift) number; holding at entry-weight targets already resets compute to ~19.4% and keeps AI-load under the 35% cap, with the mechanical layer handling any residual force-trim. MP is the lone laggard (China blacklist, weakening) but is already tiny (2.52% live) and twice-trimmed, and the DoD floor ($400M preferred + $150M loan + $110/kg NdPr floor + 10-yr offtake) is intact — trimming again on price weakness is exactly the churn to avoid. Trailing turnover is 136.7%, far over the 70% hard cap, so zero discretionary changes is correct. All 19 names held verbatim at delta 0; cash unchanged at 8.29% (within NEUTRAL band, no named cause to move it).

Reflection

AI-memory/foundry rally (MU +12%, TSM +5.5%, TER +12%) on TSMC 2027 price hikes + memory forecasts validates the compute bottleneck thesis; stale_policy blocks leaning in — hold, don't chase.

The event is confirmation, not a break — every scoped name's funder is intact or strengthened (MU/TSM scores up, copper at ATH). The 44.73% AI-load flag is drift, not sizing: re-affirming entry-weight targets self-corrects it, so I don't need to initiate trims. Tension I keep holding: MP's China-blacklist headwind recurs on the high-flag tape (87% haiku hit-rate), but it's already tiny and DoD-backstopped — churn-trimming it further is the pattern I've flagged for weeks. With turnover at 136.7% (2x the hard cap) and stale_policy blocking the only add I'd want, zero tickets is the right, quiet

Positions (18)

• MUMicron Technologycompute

  hold2.89%82
  flow acceleratingconf

  Funder

  Durable US HBM3E/HBM4 memory supplier, 84.6% GM, FCF+, capacity-disciplined cycle. Named flow: 16 Strategic Customer Agreements (~$100B contracted through 2030, ~20% DRAM/~1/3 NAND), Anthropic multi-year supply deal, ~$725B 2026 hyperscaler capex; today TSMC 10% 2027 price hike + MS 25% memory price forecast validate the shortage.

  Unwind

  DRAM/NAND spot-price collapse or HBM oversupply breaking the shortage thesis; hyperscaler capex cut; SCA contract-book erosion.

  Catalyst

  Next earnings + Q3 memory pricing print; watch for peak-pricing normalization signals.

  Scenarios · 12mo targets

  $210.00 base

  $265.00 bull — Memory shortage extends through 2027, HBM4 ramps at premium ASPs, pricing +25% holds.

  $145.00 bear — Memory cycle rolls over on capex digestion, spot DRAM/NAND collapse, HBM oversupply.

• TSMTaiwan Semiconductor Manufacturingcompute

  hold5.55%83
  flow steadyconf

  Funder

  World-leading foundry with effective monopoly at <=3nm. Every meaningful AI accelerator routes through TSMC.

  Unwind

  Gross margin sustained <50% for two consecutive quarters.

  Catalyst

  preserved

• NVDANVIDIAcompute

  hold1.59%72
  flow steadyconf

  Funder

  AI accelerator monopoly with CUDA software moat. Data-center compute platform leader of this cycle.

  Unwind

  Data-center revenue YoY <20% for two consecutive quarters.

  Catalyst

  preserved

• ASMLASML Holdingcompute

  hold1.15%64
  flow steadyconf

  Funder

  EUV and High-NA monopoly. Only viable path to leading-edge logic; structural pricing power.

  Unwind

  Book-to-bill <0.7 for three consecutive quarters.

  Catalyst

  preserved

• AVGOBroadcomcompute

  hold1.23%62
  flow steadyconf

  Funder

  Custom silicon for hyperscalers + networking + VMware moat. Diversified AI-infrastructure leverage.

  Unwind

  AI custom-chip revenue stalls below $25B annual run-rate.

  Catalyst

  preserved

• ANETArista Networkscompute

  hold1.06%67
  flow steadyconf

  Funder

  Arista Networks — durable hyperscaler networking franchise; market-share gainer since 2004, ~65% gross margin, net cash, single-image EOS software moat, Ullal-led capital discipline. Flow: Microsoft & Meta named as its largest customers funding 800G/AI back-end switching under the ~$725B 2026 hyperscaler capex wave. Replaces broken MRCY with an established compounder.

  Unwind

  Microsoft+Meta combined concentration >50% with revenue decelerating.

  Catalyst

  preserved

• CCJCamecoenergy

  hold8.43%65
  flow steadyconf

  Funder

  Tail-risk hedge slot: tier-1 Saskatchewan uranium franchise + Westinghouse 49% JV with Brookfield. DOE $17.5B AP1000 loan commitment, Kazatomprom 8Mlb output cut sustaining a structural deficit, contract book $60+/lb vs ~$93 term market. Hormuz escalation reinforces long-run nuclear energy-security demand.

  Unwind

  Uranium spot/term price collapse; contract-book erosion; DOE loan program withdrawal. Score 65 drift alone is not a trim trigger — thematic tailwind intact.

  Catalyst

  preserved

• GEVGE Vernovaenergy

  hold5.99%63
  flow steadyconf

  Funder

  Gas-turbine + grid franchise with pricing power — ~$263B backlog, 100GW turbine backlog, 10-20% price realization, 12.8% net margin, $3.7B FCF. Norway GPFG added post-spin; Oracle/Alphabet capex pull-through; Chevron JV for 4GWh behind-the-meter gas power for AI data centers (backlog +71% YoY).

  Unwind

  Backlog cancellation or wind-loss deterioration; EV/EBITDA breaching ~25x exit ceiling; a hyperscaler power-capex cut.

  Catalyst

  preserved

• SCCOSouthern Copperenergy

  hold9.21%63
  flow steadyconf

  Funder

  Copper supply deficit structural through grid electrification + AI DC build (~30% of new copper demand by 2030 per BloombergNEF). Tia Maria and Los Chancas project additions; Mexican gov dividend signal. Commodity-producer hedge slot per §5.3. Score 63 on watchlist.

  Unwind

  preserved out-of-scope

  Catalyst

  preserved

• MPMP Materialsenergy

  hold5.48%
  flow steadyconf

  Funder

  Only scaled US rare-earth + magnet producer; DoD $400M Series A preferred + $150M loan + 10-yr $110/kg NdPr price floor + 10-yr magnet offtake for the 10X facility — a government-backstopped moat vs China's 98% magnet control. Backstop intact despite the June China blacklist.

  Unwind

  FCF stays negative through the magnet ramp; China blacklist chokes processing-tech access materially; 10X construction slips; DoD backstop withdrawn.

  Catalyst

  preserved

• NEMNewmont Corporationenergy

  hold6.63%89
  flow steadyconf

  Funder

  Newmont — largest gold producer, tier-1 long-life assets, strong post-Newcrest FCF and dividend, improving cost discipline. Tail-risk equity hedge against frozen-Fed stagflation and the out-of-the-money Fed put. Flow: central-bank gold accumulation + safe-haven bid — NEM +6.8% today into Warsh's first FOMC while oil sold off.

  Unwind

  Cost overruns / mine disappointments break FCF and dividend.

  Catalyst

  preserved

• KTOSKratos Defensedefense

  hold11.11%
  flow steadyconf

  Funder

  DoD MACH-TB 2.0 IDIQ prime: $1.45B ceiling 5-year (signed Jan 6 2025); DoD Industrial Base Project Helios hypersonic materials center $68.3M single-award (Oct 2025); USMC XQ-58A Valkyrie MUX TACAIR $34.8M mod (Jan 2025); C5ISR hardware $30M (Dec 2025); aviation training $65M (Feb 2026). Pure-play on Replicator/hypersonic flow per brief §5.3.

  Unwind

  preserved out-of-scope

  Catalyst

  preserved

• HEIHEICOdefense

  hold10.30%68
  flow steadyconf

  Funder

  Defense aftermarket compounder — Mendelson family owners since 1957, 20%+ FCF CAGR sustained. Acquisition tape adding $1B+ rev annually. Wencor integration accretive. Score 68 on watchlist; NDAA mandatory funding + commercial aerospace MRO cycle dual-tailwind.

  Unwind

  Organic growth decelerates below 6% with margin compression.

  Catalyst

  preserved

• PSNdefense

  hold3.59%50
  flow steadyconf

  Funder

  Parsons — MDA SHIELD IDIQ awardee, $151B ceiling (Dec 2025); DTRA cyber-ops IDIQ $137M; USAF MATOC $15B; Navy WEXMAC TITUS 2.1 IDIQ $10B; $100M DoD munitions contract — all prime awards per Parsons IR. Iran strikes on Kuwait/Bahrain directly bid missile-defense/C-UAS integration. Mid-cap defense prime, flow_score 79.

  Unwind

  Book-to-bill falls below 1.0 two consecutive quarters

  Catalyst

  preserved

• LLYEli Lillybiology

  hold4.81%70
  flow steadyconf

  Funder

  Durable franchise: premier pharma compounder — Mounjaro/Zepbound GLP-1 franchise + retatrutide Ph3 (~70lb loss) extends a multi-decade runway, deep margins, strong capital return. Profitable and cash-generative — NOT the rate-vise cash-burner the brief warns off. Flow/timing: Norway GPFG/large AM holders; GLP-1 TAM expansion; Zealand rival failure cleared the runway. Re-establishing after a mechan

  Unwind

  Tirzepatide US script share falls >5pts to NVO over two quarters.

  Catalyst

  preserved

• VRTXVertex Pharmaceuticalsbiology

  hold3.22%76
  flow steadyconf

  Funder

  Durable biology compounder: cystic-fibrosis monopoly (Trikafta) cash engine, self-funded, high margins, fortress balance sheet — a genuine 20-30yr franchise. Tailwind: Casgevy commercializing across 12+ jurisdictions with the Medicare Cell & Gene Therapy Access Model (a named federal reimbursement flow); Journavx (suzetrigine) non-opioid pain launch; Crinetics deal adds endocrine optionality; Norw

  Unwind

  CF franchise erodes faster than non-CF revenue can replace.

  Catalyst

  preserved

• ARGXargenxbiology

  hold2.89%70
  flow steadyconf

  Funder

  argenx — Vyvgart/Vyvgart Hytrulo (efgartigimod) autoimmune franchise; self-funded commercial-stage biotech, high-margin, net cash, a durable 20-30yr FcRn franchise. Named flow: FDA expanded gMG approval to all serotypes incl. seronegative (5/28, ~18% TAM expansion); CIDP approval + MMN/SjD label expansions inflecting; peak-sales trajectory $6B→$16B by 2036; GPFG/large AM holders. Belgian ADR adds

  Unwind

  preserved out-of-scope

  Catalyst

  preserved

• LUNRcompute

  hold1.18%
  flow steadyconf

  Funder

  Intuitive Machines — NASA Near Space Network IDIQ $4.82B ceiling (active); CLPS $180.4M firm task order (Mar 2026); US Space Force Andromeda IDIQ $6.2B ceiling; $428.9M new Q1 2026 contracts from SDA+NASA; record $1.1B contracted backlog. June -22.8% is SpaceX IPO fatigue/sector, not contract loss. Within 29d lock. [steady]

  Unwind

  preserved out-of-scope

  Catalyst

  preserved

Warnings

• §2 cap applied: MU
• tilt_truncated: energy tilt +3pp ignored (pillar empty)
• tilt_truncated: biology tilt +2pp ignored (pillar empty)
• Non-US share 0.0% < 15% floor (§2/§3)
• §2 floor: FN 0.75% < 1% → closed (no dust)
• hedge_floor: only 2/3 tail-risk names held (floor escalated: AI-load 47.4% > 30%) — open a gold/oil/diversified-commodity hedge (§5.3); uranium & power-gen do not count
• patch_scope: in-scope TSM omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 6.55% (omission is not a sell, §6.5)
• patch_scope: in-scope NVDA omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 2.36% (omission is not a sell, §6.5)
• patch_scope: in-scope ASML omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 1.36% (omission is not a sell, §6.5)
• patch_scope: in-scope AVGO omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 1.83% (omission is not a sell, §6.5)
• patch_scope: in-scope ANET omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 1.57% (omission is not a sell, §6.5)
• patch_scope: in-scope FN omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 1.12% (omission is not a sell, §6.5)
• patch_scope: in-scope CCJ omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 9.95% (omission is not a sell, §6.5)
• patch_scope: in-scope GEV omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 8.9% (omission is not a sell, §6.5)
• patch_scope: in-scope SCCO omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 9.21% (omission is not a sell, §6.5)
• patch_scope: in-scope MP omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 5.31% (omission is not a sell, §6.5)
• patch_scope: in-scope NEM omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 6.43% (omission is not a sell, §6.5)
• patch_scope: in-scope LUNR omitted from the model's book with no explicit exit (exits[] / zeroed row) — restored at held 1.75% (omission is not a sell, §6.5)
• reserve_gate: intent cash 5.74% below the §5.4 working reserve 18% — new deployment gated: shrunk MU, SCCO (buying cannot drain the reserve; trims/closes rebuild it)

Conviction-lock actions

1. Turn 1ConvictionGuard (§6.5d)

   —
2. Turn 2ConvictionGuard (§6.5d)

   —
3. Turn 3ConvictionGuard (§6.5d)

   —

Cost breakdown

Per-call cost computed from cost.js pricing constants (Opus 4.7, Sonnet 4.6, Haiku 4.5). Cache-read tokens billed at 10% of input. See Cost & ROI for the rolling 30-day ledger.